CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
Rhea-AI Summary
CVS Health (NYSE: CVS) announced an expanded direct-to-consumer weight management offering centered on GLP-1 medications, combining digital care and in-store support. CVS Pharmacy now offers all FDA-approved GLP-1s, including injectable and oral options, with access via insurance and cash-pay pathways.
A new collaboration with Eli Lilly will let eligible Zepbound and Foundayo patients see transparent, reimbursed and self-pay pricing in the CVS Health app for potential same-day pickup at about 9,000 CVS Pharmacy locations by early Q4 2026. CVS also introduced a $29 MinuteClinic digital weight loss visit, with no membership or recurring fee, available 24/7 to connect eligible adults with licensed clinicians who may prescribe GLP-1 therapy and provide follow-up care.
Positive
- $29 24/7 MinuteClinic digital weight-loss visits with no membership fees
- Collaboration with Lilly to expand Zepbound and Foundayo access via CVS app
- GLP-1 out-of-pocket cost as low as $25/month with insurance and coupon
- Cash-pay GLP-1 access from $149/month using manufacturer vouchers
- Medicare GLP-1 Bridge program offers eligible patients drugs at $50/month through 2027
- Nationwide GLP-1 access and support across about 9,000 CVS Pharmacy locations
Negative
- Weight-loss program designed for self-paying adults aged 18–64, limiting eligibility
- Medicare GLP-1 Bridge program’s current pricing only runs through December 31, 2027
News Explained
CVS adds defined self-pay and covered-care terms, including a $29 visit and Medicare pricing through December 31, 2027.
The revamp adds concrete patient-facing terms: eligible self-paying adults ages 18 to 64 can use a
CVS says eligible patients may pay as little as
The MinuteClinic pathway includes health-history and goal reviews by a licensed clinician, possible GLP-1 prescribing, and follow-up visits for dose adjustments, side-effect support, and monitoring.
The separate Medicare GLP-1 Bridge pricing is available to eligible beneficiaries at
Market Reaction – CVS
Following this news, CVS has gained 2.61%, reflecting a moderate positive market reaction. Our momentum scanner has triggered 7 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $107.15.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options.
- MinuteClinic digital weight loss visits lowered to
$29 - Combines an online visit with a licensed clinician, same-day medication pickup at 9,000 local CVS Pharmacy locations, and in-person pharmacist support in one connected experience, with no membership or recurring monthly fee
- Connected businesses position CVS Health to address opportunities and deliver novel solutions in this rapidly growing category, regardless of how the prescription is reimbursed or how the consumer gets their medicine
Through CVS Health's connected care model, broader direct to consumer access to prescription drugs is easier to deliver. For GLP-1s, it's simple for eligible patients to use our scheduler technology to connect with licensed clinicians 24 hours a day through MinuteClinic®, access GLP-1 medications through CVS Pharmacy®, receive personalized pharmacist support, and use digital tools to identify available savings options. No separate memberships, no mail-order-only access, and no fragmented handoffs.
As part of this broader effort, CVS Health and Lilly are collaborating to help eligible Zepbound and Foundayo patients more easily access transparent pricing, inclusive of reimbursed and self-pay options, through the CVS Health app.
- We're making it easier for patients to navigate and find the most affordable option available to them. By early fourth quarter of 2026, eligible Zepbound and Foundayo patients will be able to view transparent pricing, including cash-pay options, in the CVS Health app for as early as same-day pickup in one of our 9,000 locations. This is in addition to already having oral and injectable formulations of Wegovy available, making CVS Pharmacy a convenient, affordable destination for all FDA approved GLP-1s.
CVS Health offers a comprehensive approach to GLP-1 support at CVS Pharmacy locations and MinuteClinic, available virtually in nearly all states.
- New offerings include expanded pharmacy support designed to help patients access these treatments and stay on them, and a new
$29
"Weight management is a deeply personal health journey, and too many people face barriers before they start treatment," said Sid Tenneti, Senior Vice President and Interim President, Pharmacy and Consumer Wellness. "CVS Health combines clinical care, pharmacy access, digital tools and trusted pharmacist support to make that journey simpler, more affordable, and more connected. Our collaboration with Lilly is one more way we're expanding direct to consumer access to help eligible patients find options that work best for them."
CVS Pharmacy offers a broad range of GLP-1 prescription medications, including both injectable and oral options from multiple manufacturers, along with new digital resources available on CVS.com.
Helping patients access lower-cost GLP-1 medications
Depending on how or whether a GLP-1 medication is covered, patients can face barriers such as prior authorization requirements, varying insurance coverage and confusion over the many ways to pay for prescriptions -- including insurance, cash-pay options, online portals, manufacturer coupons, vouchers and third-party discount cards.
CVS Pharmacy accepts a wide range of third-party prescription discount cards, manufacturer coupons and manufacturer vouchers to help reduce out-of-pocket costs. At CVS Pharmacy, the out-of-pocket cost for a GLP-1 medication can be as low as
CVS Pharmacy also participates in the Centers for Medicare & Medicaid Services Medicare GLP-1 Bridge program. The program runs through December 31, 2027, and eligible Medicare beneficiaries can access certain GLP-1 medications for
Expanding access to clinical weight loss support
At
The program is available nationally in accordance with state-level regulations and is designed for self-paying adults ages 18 to 64 who are overweight or living with obesity and intend to pay out of pocket for clinical weight loss services. Patients seeking weight loss or metabolic health clinical support can visit MinuteClinic.com.
Putting pharmacists at the center of care
According to the CVS Health 2025 Rx Report, nearly half of consumers prioritize personalized care at the pharmacy and 80 percent of patients prefer face-to-face engagements over digital, highlighting the importance of providing options to consumers. As more patients turn to GLP-1 medications, a CVS pharmacist is available in person at 9,000 locations to help them start and stay on therapy, at no additional cost.
About CVS Health
CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of June 30, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated 37 million people through a broad range of health insurance products and related services. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Media contact
Amy Thibault 401-318-2865
Amy.Thibault@CVSHealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-enhances-its-direct-to-consumer-weight-management-offerings-to-improve-access-affordability-care-and-support-for-glp-1-medications-302843020.html
SOURCE CVS Health